Acrivon Therapeutics, Inc. (ACRV) Net income 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$77.9MFY2025 · since FY2021: -$16.2M → -$77.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.9M | +3.3% |
| FY2024 | -$80.6M | -33.4% |
| FY2023 | -$60.4M | -93.8% |
| FY2022 | -$31.2M | -91.9% |
| FY2021 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACRV financial trends
ACRV RevenueACRV Net marginACRV Gross profitACRV Gross marginACRV Operating incomeACRV Operating marginACRV Operating cash flowACRV Free cash flowACRV Capital expendituresACRV Return on equityACRV Stock buybacksACRV Dividends paidACRV Total assetsACRV Total liabilitiesACRV Shareholders’ equityACRV overview →